<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended September 30, 1996
Commission File Number 0-26488
R.F. MANAGEMENT CORP.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
New York 22-3318886
-------- ----------
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
95 Madison Avenue, Suite 301, Morristown, NJ 07960
--------------------------------------------------
(Address principal executive offices) (zip code)
Registrant's telephone number, including area code (201) 292-2833
--------------
Securities Registered Pursuant to Section 12(b) of the Act: None
Securities Registered Pursuant to Section 12(g) of the Act:
Name of each exchange
Title of each class on which registered
------------------- -------------------
Common Stock
Class A Common Stock Purchase
Warrant Class B Common Stock Purchase Warrant
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 of 15(d) of the Securities and Exchange act
of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes |X| No |_|.
The number of shares outstanding of Registrant's Common Stock as of
09/30/96: 4,123,641, $.0001 par value.
<PAGE>
PART I
Item 1. BUSINESS
R.F. Management Corp. (the "Company"), through its wholly owned
subsidiary, Northern New Jersey Medical Management, Inc. ("Northern") is engaged
in the business of administering and managing a free standing outpatient center
owned by radiologists who perform diagnostic services at such Center. In May
1995, the Company entered into a Stock Acquisition Agreement with Northern New
Jersey Medical Management, Inc. ("Northern"), incorporated in the State of New
Jersey in January 1985, wherein the Company purchased all of the issued and
outstanding shares of Common Stock of Northern. Northern is now a wholly owned
subsidiary of the Company. The Company and Northern are hereinafter collectively
referred to as the Company. The Company has no plans to expand the business
conducted by Northern. In addition, the Company contracted to establish two (2)
free standing outpatient centers performing ambulatory surgery. These Centers,
once established, will be managed by the Company and owned by physicians.
Diagnostic imaging centers managed by the Company will be owned by (i) hospitals
or (ii) radiologists actively performing diagnostic procedures at such centers.
Ambulatory surgical centers managed by the Company will be owned by (i)
hospitals or (ii) surgeons who utilize such centers to perform surgery on their
own patients. The Company will not perform any medical services.
The Company focuses on obtaining patient referrals for its out-patient
surgical centers from sources such as health maintenance organizations (HMO's),
preferred provider organizations (PPO's), union contracts and hospital
contracts. The Company intends to position itself to participate in the
expanding managed healthcare market through direct solicitation of HMO's, PPO's
and physicians. See "Use of Proceeds".
Diagnostic Centers
Medical diagnostic imaging systems facilitate the diagnosis of disease and
disorders at an early stage, often minimizing the amount of cost and care needed
to stabilize or cure the patient and frequently obviate the need for invasive
diagnostic procedures, such as exploratory surgery. Diagnostic imaging systems
are based on the ability of energy waves to penetrate human tissue and generate
images of the body which can be displayed either on film or on a video monitor.
Imaging systems have evolved from conventional X-ray to the advance
technologies.
Northern's diagnostic center offers several services including X-ray
(Radiography), Ultrasonography (Ultra-sound), Mammography and Nuclear Medicine.
2
<PAGE>
Presently, the Company has no plans to expand the business conducted by
Northern.
Pursuant to a written agreement, dated January 25, 1986, the Company is
providing administrative services for an outpatient diagnostic medical imaging
center located in Union, New Jersey. The term of the agreement is twenty (20)
years. The Company is responsible for the day to day managing of the center,
including hiring and selection of non-medical employees, marketing and the
responsibility of all computer operations at the site. Medical professionals
employed by the Center provide all medical and diagnostic services at the site.
The Company is not engaged in the practice of medicine at the Center. The
Company has generated gross revenues in excess of $245,000 for each of the past
three (3) years. The Company had net income of $3,157, ($10,394) and $18,820 for
the years ended September 30, 1994, 1993 and 1992 respectively. See
"Management's Discussion and Analysis of Financial Condition and Results of
Operations."
Ambulatory Surgery Centers
An outpatient surgical center is a specially equipped physician's office
which is established to provide minor surgery which does not require the patient
to be admitted to a hospital.
The Company intends to market its services to physicians and/or hospitals
which the Company believes are seeking outpatient surgical centers. The Company
will first review the area where the proposed site is to be located and will
review a general outline or business plan. Information that will be considered
will include other centers in the area, patient financial class, patient
demographics in the area served, and potential subscribers to the service. In
the case of a hospital, the Company will consider the number of diagnostic or
outpatient surgical procedures that the hospital can provide. Managed care
groups and HMO's will be contacted to determine if contracts for providing
services are available and to ascertain the membership in the service area of
the potential new sites. If the site is considered to be positive, a request
will be made to the equipment manufacturers for a bid on the equipment the
Company deems necessary. After all information needed by the Company is
received, the Company will determine the financial viability of the project.
Based on the criteria above, the Company will review each site to determine if
utilization and proliferation of the equipment and services is a concern.
The Company will not own any interest in these planned centers. For
consideration of the management fee the Company receives, the Company will
provide all startup funding necessary, including the purchase of medical and
surgical equipment, and all administrative, marketing and management functions.
See "Use of Proceeds."
3
<PAGE>
The Company will establish Centers, then service (support) these centers
by providing administrative, marketing and management functions. As part of the
Company's planned operations, the Company will purchase or lease equipment to be
utilized in the surgical centers. The cost of such equipment will be factored in
to the calculation for the management fee to be charged to the
physician/hospital who owns the Center. In addition to the cost of the
equipment, various other factors including the particular services required at a
particular center, will be factored into the management fee.
The Company will offer a full range of administrative services, including
contract negotiations, site selection, equipment procurement, construction,
office personnel, office management, patient scheduling, patient billing, cash
collections, personnel management and marketing. The Company can provide either
a full or limited range of administrative services at the Centers depending upon
the needs of the Centers owners.
The Company has arranged for financing to lease all the equipment and
space necessary to provide a surgical suite to a physician or a group of
physicians to practice medicine in a private office. The Company will offer a
full range of services to hospitals or physician clients, including the
selection and acquisition of appropriate equipment, the design and supervision
of facility construction, the provision and training of technical and support
staff, patient billing and collection and the provision of overall marketing and
management services. The equipment which the Company will procure will include
but is not limited to surgical tables, crash carts, monitoring equipment, all
diagnostic imaging equipment and surgical instruments needed to operate a
diagnostic and/or out-patient surgical center.
The Company was incorporated in the State of New York in August, 1994 and
its executive offices are located at 95 Madison Avenue, Suite 301, Morristown,
New Jersey 07960. It's telephone number is (201) 292-2833.
Range of Services
The Company provides the full range of services discussed below. The needs
of a particular hospital or physician group determines the extent of the
services provided by the Company at a particular Center. The Company can deliver
services on a limited basis or through a full service medical center.
Equipment and Related Services. The Company consults with a physician or
hospital to identify the equipment best suited to meet the customer's needs on a
cost-effective basis and then acquire the equipment through lease/purchase
agreement. In addition, the Company assists the physicians and their personnel
in complying with licensing and other regulatory requirements. The Company
4
<PAGE>
supervises the installation and testing of the equipment and provides periodic
inspection of the equipment at the facility. The Company undertakes to maintain
the equipment which it provides and enters into agreements with equipment
manufacturers or other third parties for the delivery of maintenance services.
Technical and Support Staffing. The Company provides non-physician
staffing who operate the equipment at the facility. The Company trains and
provide on-going safety instruction and educational programs for its staff. The
Company does not provide any medical services at the Center.
Marketing. The Company provides its customers with marketing services,
including the design and formulation of a marketing program for each facility to
inform the physician community as to the technology and services available at
the facility.
Patient Scheduling, Billing and Collection. At the Centers, the Company
schedules patients and prepare all patient billing and is responsible for
collection. The Company will also be responsible for related administrative and
record-keeping functions and all management information services.
Management. The Company assumes full managerial responsibility over
facility operations, including all of the foregoing services, at each of the
future Centers.
Delivery of Services
The Company delivers its services to its customers through either
contractual arrangements with hospitals or medical center arrangements with
physician groups.
Growth Strategy and Marketing
The Company markets its services to physicians and hospitals through
various methods. These include direct solicitation, direct mail, sponsorship of
inservice education programs for physicians, nurses and technical staff, and
personal visits to physician offices. The Company also attends many of the
surgical seminars throughout the country.
The Company is pursing a strategy of aggressively seeking to establish new
hospital centers with hospitals which currently have existing centers as well as
with hospitals without existing centers. In addition, the Company attempts to
educate surgeons as to the benefit of establishing their own ambulatory surgical
center, to which the Company can offer its services. The Company engages in
intensive marketing in areas of specialized physicians group, HMO's, PPO's,
union locals, municipalities and insurance companies. The Company attempts to
negotiate discounts with large suppliers of patients as allowed by law. The
Company's objective
5
<PAGE>
is to respond to the concerns of spiraling health costs while maintaining
quality of care to the patient. This is attainable based on the premise that
increased volume results in a reduction of cost per procedure which is passed
along to the Company's contracted clients.
The Company applies a variety of criteria in evaluating each perspective
hospital customer. These criteria include the extent of the hospitals'
competitive environment; the site and type of hospital; the number of surgical
and orthopedic physicians, the patient volume and the nature of the payors
(private insurance programs, government reimbursement programs or other health
or medical organizations). The Company performs a similar analysis regarding
physician owned centers.
The Company's plan of operation is to identify and establish customers
during the remainder of this year. The Company, with its direct marketing
efforts, continues to seek clients, whether through acquisition of sites or
startups.
Equipment Sources
The Company can obtain its medical equipment and supplies from various
manufacturers. The Company is not dependent on any one supplier of equipment.
The Company believes that equipment should be financed by the Company (typically
with terms of five years) with lenders and lessors, with equipment serving as
security for the loans. The Company's acquisition methods (purchase or lease)
depends upon the specific circumstances of each transaction.
Northern New Jersey Medical Management, Inc.'s Stock Acquisition Agreement With
the Company.
In May 1995, the Company entered into a Stock Acquisition Agreement (the
"Agreement") with Northern New Jersey Medical Management, Inc. ("Northern") a
corporation formed in the State of New Jersey in January 1986 with offices
located at 95 Madison Avenue, Morristown, New Jersey 07960. Northern was and is
engaged in the business of administering and managing a free standing outpatient
center performing diagnostic services prior to the acquisition. The sole
officers, directors and principal shareholders of Northern were Roger Findlay
and Gregory Maccia, who are officers, directors and principal shareholders of
the Company.
Pursuant to the terms of the Agreement, the Company purchased all of the
issued and outstanding shares of common stock of Northern. In consideration, the
Company will pay Messrs. Findlay and Maccia an aggregate of $750,000 in
accordance with the following terms:
$150,000 paid upon execution of the agreement; the balance of
$600,000 will be paid in the form of
6
<PAGE>
a promissory note, with interest at prime plus 1% on the unpaid
principal balance, payable as follows:
$150,000 on January 30, 1996;
$150,000 on January 30, 1997;
$150,000 on January 30, 1998;
$150,000 on January 30, 1999.
In the event that the gross annual revenue for any calendar year from
1995-1998 for Northern falls below $200,000 then the payment due on January 30
of the subsequent year will be reduced by 1/3, and the amount left unpaid by
reason of such adjustment shall be forfeited. The Company and Northern further
agreed, that all payments pursuant to the promissory note will only be
distributed from operating revenues and not from the Use of Proceeds of the
Offering. The Company will not use or finance the purchase of Northern with
proceeds from the Offering. In no event will the indebtedness payments by the
Company exceed actual revenues received. In the event that revenues are
insufficient to pay the indebtedness the indebtedness will accrue.
For the past three years ended September 30, 1995, 1994 and 1993, Northern
has generated gross revenues of approximately $355,000, $333,000 and $281,000,
respectively ,and net income (loss) of $23,460, $3,157 and $(10,394),
respectively. Messrs. Findlay and Maccia have represented that they will not be
receiving any salary or compensation from the operation and affairs of Northern
subsequent to the closing date. In the event that there are inadequate revenues
from the operations of Northern, Messrs. Findlay and Maccia's payments under the
Agreement will be accrued.
In addition, both the Company and Northern made standard representations
and warranties with respect to their respective operations and affairs. Northern
now operates as a wholly owned subsidiary of the Company. Northern further
represented and warranted that its present contract in Union, New Jersey will
remain in full force and effect for an additional eleven years.
LICENSES, REGULATION AND GOVERNMENTAL REIMBURSEMENT
Licenses. The Company provides administrative and management services to a
free standing outpatient center performing diagnostic imaging, located in Union,
New Jersey. The diagnostic imaging center is owned by radiologists who actively
perform diagnostic testing at such center. In addition, the Company intends to
establish free standing outpatient centers performing ambulatory surgery. The
ambulatory surgical centers will be owned by surgeons to perform surgery on
their own patients. The Company does not perform medical services. However,
government regulations do apply to the Company with respect to payment on third
party Medicare and Medicaid reimbursement. The Company will be subject to the
Anti-Kickback Laws, the "Stark Bill" as well as in New Jersey, the
7
<PAGE>
Health Care Cost Reduction Act which are discussed herein. In the future,
however, the Company may be required to maintain licenses or certificates of
need issued by individual states. A number of states require hospital physicians
to obtain a Certificate-of-Need ("CON") prior to the development of the surgical
centers. The CON programs vary considerably from state to state, but all attempt
to regulate the ambulatory surgery services. Some states regulate indirectly
through rate commissions which prescribe hospital rates. The Company intends to
engage in business in New Jersey. Presently, in the State of New Jersey one room
surgical suites are excluded from the Certificate of Need (CON) requirements.
However, if the Company were to plan for the operation of a multi-suite center,
a CON would have to be filed with the appropriate state agency.
Government Reimbursement. In major areas of its business, the Company may
rely for payment on third party (in large part governmental) reimbursement. Its
charges are predominantly paid by its clients which in turn receive
reimbursement from such sources.
The Center that the Company is affiliated with will participate in many
reimbursement programs such as Medicare and Medicaid as well as other private
insurers. Under these arrangements the Center agrees to accept the approved
amount of reimbursement from each individual payor. Monthly statements are only
sent out when allowed by contractual arrangements with the insurers.
Regulations. In order to curb the potential for fraud and abuse under the
Medicare and Medicaid programs, Congress has enacted certain laws (the
"Anti-Kickback Laws") prohibiting the payment or receipt of any remuneration in
return for the referral of patients to a healthcare provider for the furnishing
of medical services or equipment, the payment for which may be made in whole or
in part by the Medicare or Medicaid programs. New Jersey, as well as other
states, have enacted similar laws. It should be noted that the Anti-Kickback
Laws apply to both sides of the referral relationship: the provider making the
referral and the provider receiving the referral. Violation of the Anti-Kickback
Laws is a criminal felony punishable by fines of up to $25,000 and/or up to five
years imprisonment for each violation. Federal law also permits the Department
of Health and Human Services ("HHS") to assess civil fines against violators of
the Anti-Kickback Laws and to exclude them from participation in the Medicare
and Medicaid programs. These civil sanctions can be imposed in proceedings that
do not involve the same procedural requirements and standards of proof as would
be required in a criminal trial.
The Anti-Kickback Laws are broadly drafted and judicial decisions rendered
thus far, while made in the context of overt
8
<PAGE>
payments explicitly in exchange for referrals, have broadly interpreted the
scope of these laws. Several federal courts considering the issue, including the
U.S. Court of Appeals having jurisdiction over New Jersey, have concluded that
the Anti-Kickback Laws would be violated if "any purpose" of a challenged
economic arrangement is to induce or pay for referrals, no matter how incidental
that purpose may be or how many other legitimate purposes may exist for the
arrangement in question. Accordingly, many types of business relationships
between healthcare providers, including investments in healthcare providers by
physicians, hospitals or others who are in a position to refer patients could be
held to fall within the prohibitions of the Anti-Kickback Laws or similar state
laws.
The American Medical Association (the "AMA") has reaffirmed its original
Guidelines which were issued on May 6, 1992, which stated that physicians should
not refer patients to a healthcare facility outside their office in which they
do not have an active participation and only a passive investment interest.
These are ethical rules and recommendations of the AMA and they do not have a
binding legal effect. Since the Company is not in the practice of medicine these
AMA Guidelines do not apply to the business of the Company.
HHS has proposed regulations specifying "safe harbors" for various payment
practices between healthcare providers and their referral sources; that is, if a
payment practice were to come within the safe harbor, it would not be treated as
an illegal Medicare/Medicaid kickback or grounds for exclusion from the
Medicare/Medicaid programs. While failure to fall within a safe harbor does not
mean that the practice is illegal, HHS had indicated that it may give such
arrangements closer scrutiny. In their present proposed form, no safe harbor
would cover an investment interest in the Company. Congress has enacted
legislation (the "Stark Law") which generally prohibits an entity from
furnishing a service to an individual for which payment would be made by
Medicare or Medicaid if the individual's referring physician, or an immediate
family member of such referring physician, had an ownership or other financial
interest in the entity. The Company cannot predict whether other regulatory or
statutory provisions will be enacted by federal or state authorities which would
prohibit or otherwise regulate referrals by physicians to the Company.
In 1991, New Jersey enacted the Health Care Cost Reduction Act, or
so-called "Codey Bill", (N.J.S.A. 45: 9-22.4 et seq.) which provided in part
that a medical practitioner shall not refer a patient, or direct one of its
employees to refer a patient, to a health care service in which the practitioner
and/or the practitioner's immediate family had any beneficial interest. The bill
specifically provided that for beneficial interests which were created prior to
the effective date of the Act, July 31, 1991, the
9
<PAGE>
practitioner could continue to refer patients, or direct an employee to do so,
if the practitioner disclosed such interest to his patients. The disclosure must
take the form of a sign posted in a conspicuous place in the practitioner's
office informing the patients of such interest and stating that a listing of
alternative health care service providers could be found in the telephone
directory.
Under the "Stark Law", a physician who has a financial relationship with
an entity may not make a referral to the entity for the furnishing of clinical
laboratory services for which payment is made under the Medicare or Medicaid
programs. The Stark Law expands the application of the Medicare ban on
self-referrals after December 31, 1994. The Stark Law also extends the
self-referral ban to physician therapy services, radiology services including
MRI and CT scans, ultrasound services, radiation therapy services and the
furnishing of durable medical equipment, the furnishing of parenteral and
enteral nutritional equipment and supplies, the furnishing of out-patient
prescription drugs, ambulance services, home infusion therapy services,
occupational therapy services and in-patient and out-patient hospital services
(including services furnished in a psychiatric or rehabilitation hospital).
The diagnostic center currently managed by the Company is owned by
radiologists who actively engage in the performance of diagnostic testing at the
Centers. No investment interest or financial relationship exists between the
Center and any physician who is not a radiologist administering procedures at
the Center. The Company's planned surgical centers will be owned by surgeons who
will utilize the Centers to perform surgical procedures on their own patients.
No ownership interest or financial relationship will exist between such Centers
and any physician who is not a surgeon performing operations on his/her patient
at such Centers. The Company will not have any ownership or financial interest
in the outpatient surgical or diagnostic imaging centers other than the
administration and management of such centers pursuant to written agreements.
The Company has received an independent legal opinion from Andrew B. Schultz,
Esq. regarding the cited federal Anti-kickback Law and Stark Law. Based on the
business of the Company and the factual assertions provided by the Company that
its activities involve management and administrative services of certain
ambulatory surgical and diagnostic imaging facilities to be owned by physicians,
Mr. Schultz has opined that at this time there would be no substantial legal
basis to establish any violation by the Company of the cited Anti-Kickback Law
or the "Stark Law". The Company's services will be offered to and its Center
owned by people who are highly regulated. To the extent that these individuals
are affected by government regulations including the Anti-Kickback Laws, the
Company will be affected. The Centers will be owned by physicians. In the event
that the Company engages in other than management and administrative
10
<PAGE>
services at the Center and/or the Centers not owned by physicians then Mr.
Schultz's opinion may not be relied on with respect to whether in fact the
regulations apply. In the event that the Company is determined by governmental
or judicial authorities to be in violation of either the federal Anti-Kickback
Law or the Stark Law, the Company would be subject to criminal and civil
penalties.
Competition
The Company competes with many firms that offer similar services. This
segment of the industry is highly competitive and many of the Company's
competitors have financial, marketing and other resources substantially greater
than those of the Company. Some of the Company's competitors enjoy an additional
competitive advantage by reason of their ability to offer discounts and other
services. Accordingly, the Company seeks to address smaller markets which have a
need for free standing or out-patient centers performing diagnostic or
outpatient ambulatory surgery. The Company has identified the State of New
Jersey as its area of operation because of its favorable legislation regarding
one room surgical and diagnostic suites.
The medical diagnostic business is characterized by a high degree of
competition. In the Company's case, this competition comes from a number of
independent local operators specializing in one or two medical applications, and
from a few large diversified healthcare companies (primarily larger hospitals
having the resources and capability to provide mobile diagnostic services to
other healthcare facilities) which provide ultrasound and other diagnostic
services as part of their overall medical business. Although the Company
believes that is has a competitive advantage over most of the small operators
(the Company competes in its marketplace based upon its performance, marketing
and its ability to customize its contractual arrangement), the Company may be
vulnerable to competition from the larger healthcare companies, at lease one of
which can be found in each of the Company's geographic markets, and all of which
are substantially larger and possess greater financial resources than the
Company.
Marketing
The Company markets its services through direct solicitation by various
employees, as well as direct mail, independent marketing companies, medical
staff in-service programs, and personal sales visits to physicians, the primary
emphasis of which is to educate the physician about program services. In
addition, the Company will focus its marketing efforts by obtaining patient
referrals to its centers from sources such as health maintenance organizations
(HMO), preferred provider organizations (PPO), union contracts and hospital
contracts. The Company will position itself to participate in the expanding
managed healthcare market through direct solicitation of HMO's, PPO's and
physicians. The Company
11
<PAGE>
intends to establish joint ventures with hospitals and physician managed
ambulatory surgery centers to provide services to subscribers at reduced rates.
See "Use of Proceeds".
Insurance
The Company carries general liability insurance with coverage of up to
$1,000,000.00 per claim and a commercial umbrella policy of $2,000,000. The
Company believes that such coverage will be adequate.
Employees
As of September, 1996, the Company employed 6 persons on a full-time
basis. Of the 6 employees, 4 are in management, 1 is in sales/marketing and 1 is
clerical/administrative.
Item 2. PROPERTIES
The Company's offices, at present, are located at 95 Madison Avenue, Suite
301, Morristown, New Jersey 07960. These premises are leased by Northern. The
premises are utilized by Northern, the Company and other entities related to the
Company and/or the management. Expense in connection with the use of such
premises are allocated among the businesses that share the facility. At this
time, the Company does not have any proposals for new facilities for its
proposed operations.
Item 3. LEGAL PROCEEDINGS
The Company is not a party to any legal proceedings.
Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
None.
12
<PAGE>
PART II
Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
R.F. Management Corp.'s initial public offering closed on July 21, 1995.
Neither a cash or stock dividend has been paid or issued.
The Company's Common Stock is traded in the NASDAQ over-the-counter market
under the symbol RFMC. It's "A Warrant" and "B Warrant" are traded under the
symbols RFMCW and RFMCZ. As quoted in the Monthly Statistical Reports of the
National Association of Securities Dealers, Inc., the approximate high and low
bid prices for the year ended September 30, 1996 are as follows:
COMMON STOCK
Date High Low
---- ---- ---
10/95 7 3/2 6 5/6
11/95 8 0/8 7 0/8
12/95 8 1/6 7 2/4
01/96 7 5/6 6 0/8
02/96 6 3/6 5 4/0
03/96 5 5/2 4 1/0
04/96 4 3/2 2 3/2
05/96 3 1/6 2 4/0
06/96 4 0/8 2 4/8
07/96 3 3/2 1 4/8
08/96 2 0/4 4/8
09/96 1 3/2 5/2
A WARRANT
Date High Low
---- ---- ---
10/95 2 4/8 2 3/2
11/95 3 1/6 2 3/2
12/95 3 1/6 2 3/2
01/96 3 1/6 2 0/8
02/96 2 4/0 2 0/0
03/96 2 0/8 1 0/8
04/96 1 3/2 5/6
05/96 1 1/6 5/6
06/96 1 1/6 4/8
07/96 1 0/8 1/6
08/96 2/4 0/8
09/96 2/0 1/6
13
<PAGE>
B WARRANT
Date High Low
---- ---- ---
10/95 1 3/2 1 1/6
11/95 2 1/6 1 1/6
12/95 2 1/6 1 4/6
01/96 2 1/6 1 1/6
02/96 1 4/8 1 0/0
03/96 1 0/8 4/0
04/96 1 1/6 4/0
05/96 4/4 3/2
06/96 4/0 1/6
07/96 4/0 2/4
08/96 2/4 1/2
09/96 1/6 1/2
14
<PAGE>
Item 6. SELECTED FINANCIAL DATA
The selected financial data presented below as of September 30, 1996,
1995, 1994, 1993 and 1992 were derived from the Company's financial statements.
The information set forth below is qualified in its entirety by reference to,
and should be read in conjunction with, the financial statements and related
notes contained elsewhere in this Form 10-K.
Selected Statement of Operations Data:
<TABLE>
<CAPTION>
1 9 9 6 1 9 9 5 1 9 9 4 1 9 9 3 1 9 9 2
------- ------- ------- ------- -------
<S> <C> <C> <C> <C> <C>
Operating revenue $ 312,971 355,029 333,002 281,445 248,448
Operating expenses 1,579,288 458,047 331,622 299,853 220,657
Income (loss) from
operations (1,170,018) (75,012) 1,380 (18,408) 27,791
Net income (loss) (952,214) (50,244) 3,157 (10,394) 18,820
Earnings (loss)
per share (.29) (0.02) NIL NIL NIL
Selected Balance Sheet Data:
Working Capital $ 2,905,272 4,513,996 102,599 151,742 151,381
Total Assets 3,876,151 4,814,154 158,096 160,113 157,721
Total Liabilities 697,971 683,760 98,432 105,606 92,820
Shareholders'
Equity 3,178,180 4,130,394 59,664 54,507 64,901
</TABLE>
15
<PAGE>
Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
Introduction
R.F. Management Corp. (the "Company") was formed in August of 1994, for
the purpose of establishing, administrating and managing free-standing
outpatient ambulatory surgery centers. In 1995 the Company acquired 100% of the
outstanding shares of Northern New Jersey Medical Management, Inc. ("Northern")
in a business combination accounted for as a pooling of interests. Northern, a
New Jersey corporation formed in 1986, is engaged in the management of a
diagnostic imaging center located in Union, New Jersey. All references to the
Company's prior operating history relates to the operations of Northern.
The Company presently administers and manages one outpatient diagnostic
center located in Union, New Jersey. The Company is responsible for the day to
day management of the site, including hiring and selection of non-medical
employees, marketing and the responsibility of all computer operations at the
site. Medical professionals employed at the Center provide all medical and
diagnostic services at the site. The Company is not engaged in the practice of
medicine.
All contract negotiation by the Company to manage two (2) outpatient
surgical sites for St. Mary's Hospital in Passaic, New Jersey, have been
terminated after failure to reach satisfactory terms. The Company has entered
into letters of intent to administer free standing ambulatory surgical centers
with the following: Ambulatory Surgery Center of Morris County, Inc. D/B/A
Ridgedale Surgery Center on February 24, 1996, Middlesex Ambulatory Surgical
Center (East Brunswick, New Jersey) on March 26, 1996, Ocean OB/GYN Associates
(Toms River, New Jersey) on July 15, 1995, Michael Schalet, D.O. (Morristown,
New Jersey) on June 21, 1995, Monica Mehta, M.D. and H. Shah, M.D. (Jersey City,
New Jersey) on October 4, 1995, M. Fateh, M.D. (Millburn, New Jersey) on July
13, 1995, N.S. Botros, M.D. (Bayonne, New Jersey) on October 25, 1995, and
Rameth Tandom M.D. (Montville, New Jersey) on April 10, 1996. The Company has
also entered into a letter of intent with Luther W. Brady, M.D. Associates P.C.,
to administer three Radiation Therapy Centers.
On December 27, 1995, R.F. acquired forty (40%) of the outstanding shares
of Mobile Medical Services Limited ("Mobile"), a privately held Comapny
incorporated in Ireland, and a fifty-one (51%) interest in the property owned or
leased by its subsidiaries for $350,000. Mobile Medical Services Limited
provides mobile MRI, CT, Lithotripsy and Cardiac Catheterization services in the
Netherlands, United Kingdom, Italy and Germany. The payment terms call for the
Comapny to make payments directly to designated creditors on behalf of Mobile.
As of September 30, 1996, $350,000
16
<PAGE>
is reflected as an investment in joint venture.
On March 20, 1996 the Company formed a wholly-owned subsidiary, R.F.
Management Corp. of Toms River "RFTR", a New Jersey corporation, who in July
1996 entered into a lease and management service agreement with Surgical
Associates, PA. This agreement is to commence upon the completion of the
construction of a one room surgical suite.
On May 30, 1996, the Company entered into a five year lease and management
service agreement with Associates in Otolaryngology of New Jersey, PA. This
agreement is to commence upon the completion of the construction of a one room
surgical suite.
Results of Operations
Year ended September 30, 1996 compared to the year ended September 30,
1995:
Results of operations, which presents operating data for the Company and
Northern New Jersey Medical Management, Inc. reflects total operating revenues
of $313,000 as compared to approximately $355,000 in 1995, a decrease of
approximately $42,000 or 12%. The decrease in management fees resulted from a
decrease in the realization under third party reimbursement agreements at the
diagnostic imaging center it manages.
Operating expenses for the year ended September 30, 1996 were
approximately $1,579,000 , as compared to approximately $458,000 for the year
ended September 30, 1995, an increase of approximately $1,121,000. Management
attributes this increase to expenditures made for salaries, professional fees,
consulting expenses and travel and entertainment costs associated with efforts
to establish and manage new and existing surgical centers.
Interest expense for the year ended September 30, 1996 was approximately
$56,000 as compared to approximately $14,000 for the year ended September 30,
1995. This is primarily attributed to the unpaid principal pertaining tot he
acquisition of Northern on May 31, 1995 which accrues interest at the rate of
prime plus one percent. In addition, on April 30, 1996, a bank line of credit
was established bearing interest at prime plus one percent.
Interest income aggregated approximately $175,000 for the year ended
September 30, 1996 as compared to approximately $44,000 for the year ended
September 30, 1995. This increase of approximately $131,000 is due to the
Company's investment balance from the proceeds of the initial public offering.
Net loss increased to approximately $952,000 or $.29 per share for the
year ended September 30, 1996 as compared to $50,000 or $.02 for the year ended
September 30, 1995, on a primary basis.
17
<PAGE>
The explanation of this increase is a direct result of the increase in expansion
associated with the efforts to establish new and existing surgical centers.
The healthcare dollar for the past few years has been earmarked for
reductions. although third party payors are shrinking the amount of healthcare
payments, quality care and highly technological equipment is still a priority.
With increases in the cost of highly technological equipment and the cost to
borrow money, profit margins will be reduced. It is the Company's aim to address
the effects of lower healthcare reimbursement and increased equipment costs by
handling a larger volume of patients at its newly acquired centers and at its
future centers through a managed care network.
Year ended September 30, 1995 compared to the year ended September 30, 1994:
Management fees for the year ended September 30, 1995 were approximately
$335,000 as compared to approximately $333,000 for 1994, an increase fo
approximately $22,000. This increase is attributable to an increase in referrals
and the number of patients handled at the center.
Operating expenses for the year ended September 30, 1995 aggregated
approximately $458,000 as compared to approximately $331,000 in 1994, an
increase of approximately $127,000. Management attributes this increase
primarily to the establishment of a sales and marketing team and the
expenditures associated with their efforts to establish and manage new Surgical
Centers.
Interest income aggregated approximately $44,000 for the year ended
September 30, 1995 as compared to $0 for the year ended September 30, 1994. This
increase is due to the investment income earned on the proceeds of the initial
public offering.
Net loss for the year ended September 30, 1995 aggregated approximately
$50,000 as compared to net income of approximately $3,000 for the year ended
September 30, 1994. Explanation of this decrease can be derived from the
operational analysis provided above.
Liquidity and Capital Resources
On December 15, 1994, the Company completed a Private Placement Offering
of its $.0001 par value Common Stock. The offering, which raised for the Company
$700,000 before expenses, called for the sale of up to 4,100,000 shares at a
price of $2.00 per share (giving effect to the 4-for-1 stock split on December
22, 1994). The Company closed the offering upon the sale of 350,000 shares
(giving effect to the 4-for-1 stock split on December 22, 1994), which raised
the Company $615,995, net of expenses.
18
<PAGE>
On July 21, 1995, the Company's Initial Public Offering was declared
effective by the United States Securities and Exchange Commission and closed on
July 27, 1995. the offering included the sale of 977,500 shares of common stock,
977,500 A Warrants and 977,500 B Warrants. The Company received proceeds of
$4,205,899, net of expenses of $1,365,851.
The Company has a working capital surplus of $2,905,272 at September 30,
1996 when compared to a working capital surplus of $4,513,996 at September 30,
1995. This decrease is primarily the result of expenditures incurred in the
expansion and development of new business.
The Company experienced a net decrease in cash and equivalents aggregating
approximately $2,362,000 for the year ended September 30, 1996. This decrease
results primarily from the net loss and other operating activities aggregating
approximately $1,442,000, the investments in a joint venture, certificate of
deposit and fixed assets aggregating approximately $882,000 and the repayment of
$150,000 of notes payable to stockholders less advances from a line of credit of
approximately $168,000.
On April 30, 1996, the Company entered into a one year $400,000 line of
credit agreement with a bank which bears interest on the unpaid principal at
prime plus one percent (9.25%). The line is collateralized by a one year
certificate of deposit. As of September 30, 1996, the amount outstanding under
the line of credit aggregated approximately $168,000.
The Company believes that it has sufficient resources to support the
operations of Northern and begin its proposed surgical center operations and it
has working capital to administer and manage the centers for the next twelve
months. The Company believes that the net proceeds from the Initial Public
Offering will be sufficient to meet its plans with respect to the management and
the administration of sites in the next twelve months and its working capital
needs for the foreseeable future. It is the belief of the Company that the
normal cash flow generated from the administration and management from the
Centers will provide excess cash (capital) which will be used for expenses and
future capital needs.
The Company further believes that the operations of Northern will provide
sufficient capital (net of expenses) and cash flows to repay the annual
installments of $150,000 for the loan payable, plus interest due to Northern's
former shareholders. If funds from Northern's operations are not sufficient for
repayment of the annual installments, the installments will be reduced to
$100,000 if the gross annual revenues fall below $200,000 and the amount left
unpaid by reason of such adjustment shall be forfeited.
19
<PAGE>
There are no other known trends, demands, commitments or events that will
impact the Company's results of operations, liquidity and/or capital resources.
Item 8. FINANCIAL STATEMENT AND SUPPLEMENTARY DATA
Index to Consolidated Financial Statements of R.F. Management Corp. and
Subsidiaries as of September 30, 1996 and 1995 and for the three year period
ended September 30, 1996.
Page
----
Independent Auditors' Report F-1, F-2
Consolidated Financial Statements
Consolidated Balance Sheets F-3, F-4
Consolidated Statements of Operations F-5
Consolidated Statements of Stockholder's Equity F-6
Consolidated Statements of Cash Flows F-7, F-8
Notes to Consolidated Financial Statements F-9,F-16
20
<PAGE>
[LETTERHEAD OF DDK & COMPANY LLP]
Independent Auditors' Report
To the Board of Directors and Stockholders
of R.F. Management Corp.
We have audited the accompanying consolidated balance sheets of R.F.
Management Corp. and Subsidiaries as of September 30, 1996 and 1995, and the
related consolidated statements of operations, stockholders' equity, and cash
flows for each of the three years in the period ended September 30, 1996. These
financial statements are the responsibility of the Company's management. Our
responsibility is to express an opinion on these financial statements based on
our audits. We did not audit the financial statements of Northern New Jersey
Medical Management, Inc., a wholly-owned subsidiary, which statements reflected
total assets of $255,388 and $159,871, as of September 30, 1996 and 1995, and
total revenues of $309,067, $355,029, $333,002, for the three year period ended
September 30, 1996. Those statements were audited by other auditors whose report
has been furnished to us, and our opinion, insofar as it relates to amounts
included for Northern New Jersey Medical Management, Inc., is based solely on
the report of the other auditors.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatements. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits and the report of the other auditors provide a
reasonable basis for our opinion.
In our opinion, based on our audits and the report of other auditors, the
consolidated financial statements referred to above present fairly, in all
material respects, the financial position of R.F. Management Corp. and
Subsidiaries as of September 30, 1996 and 1995, and the results of their
operations and their cash flows for each of the three years in the period ended
September 30, 1996 in conformity with generally accepted accounting principles.
Our audits of the foregoing financial statements also included the
schedules listed in answer to Item 14(a)(3). In our opinion, such schedules
present fairly the information required to be set forth therein.
/s/ DDK & Company LLP
DDK & COMPANY LLP
Certified Public Accountants
New York, New York
December 6, 1996
F-1
<PAGE>
Independent Auditors' Report
To the Board of Directors and Stockholders:
Northern New Jersey Medical Management, Inc.
We have audited the accompanying balance sheets of Northern New Jersey Medical
Management, Inc. as of September 30, 1996 and 1995, and the related statements
of income, changes in stockholders' equity and cash flows for each of the three
years in the period ended September 30, 1996. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We have conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used an significant
estimates made by management, as well as evaluating the overall financial
statements presentation. We believe that our audits provide a reasonabe basis
for our opinion.
In our opinion, the financial statements referred to above present fairly in all
material respects the financial position of Northern New Jersey Medical
Management, Inc. as of September 30, 1996, and 1995, and the results of its
operations and its cash flows for the three year period ended September 30, 1996
in conformity with generally accepted accounting principles.
/s/ Davenport & Associates, PA
DAVENPORT & ASSOCIATES, PA
Certified Public Accountants
Colonia, New Jersey
November 20, 1996
F-2
<PAGE>
R.F. MANAGEMENT CORP.
Consolidated Balance Sheets
September 30, September 30,
1996 1995
------------- -------------
ASSETS
Current assets
Cash and cash equivalents $2,258,333 $4,620,520
Certificate of deposit 408,266 --
Accounts receivable 296,893 90,618
Due from affiliate 19,743 19,743
Deferred income taxes 218,798 451
Other current assets 101,210 16,424
---------- ----------
Total current assets 3,303,243 4,747,756
---------- ----------
Other assets
Furniture, fixtures, equipment and leasehold
improvements (net of accumulated depreciation
of $24,969 and $2,201, respectively) 130,730 30,142
Investment in a limited partnership 11,120 10,985
Investment in joint venture 350,000 --
Note receivable -- 20,000
Deposits and other assets 80,866 5,030
Organization costs (net of accumulated
amortization of $76 and $27, respectively) 192 241
---------- ----------
Total other assets 572,908 66,398
---------- ----------
TOTAL ASSETS $3,876,151 $4,814,154
========== ==========
See Notes to Consolidated Financial Statements.
F-3
<PAGE>
R.F. MANAGEMENT CORP.
Consolidated Balance Sheets
(continued)
September 30, September 30,
1996 1995
------------- -------------
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Line of credit $ 167,700 $ --
Accounts payable 47,505 29,500
Accrued expenses 32,766 50,435
Income taxes payable -- 3,825
Notes payable - stockholders 150,000 150,000
---------- ----------
Total current liabilities 397,971 233,760
Other liabilities
Notes payable - stockholders 300,000 450,000
---------- ----------
TOTAL LIABILITIES 697,971 683,760
---------- ----------
Commitments and contingencies
Stockholders' equity
Common stock, $0.0001 par value,
15,000,000 shares authorized,
3,327,500 and 3,327,500 shares issued
and outstanding 333 333
Additional paid-in capital 4,123,641 4,123,641
Retained earnings (deficit) (945,794) 6,420
---------- ----------
TOTAL STOCKHOLDERS' EQUITY 3,178,180 4,130,394
---------- ----------
TOTAL LIABILITIES AND
STOCKHOLDERS' EQUITY $3,876,151 $4,814,154
========== ==========
See Notes to Consolidated Financial Statements.
F-4
<PAGE>
R.F. MANAGEMENT CORP.
Consolidated Statements of Operations
<TABLE>
<CAPTION>
Years Ended September 30,
---------------------------------------
1996 1995 1994
----------- ----------- -----------
<S> <C> <C> <C>
REVENUES
Management fees $ 312,971 $ 355,029 $ 333,002
----------- ----------- -----------
COSTS AND EXPENSES
Operating expenses 1,579,288 458,047 331,380
Interest 55,615 14,259 --
Depreciation and amortization 22,817 1,836 242
Interest income (174,731) (44,101) (52)
----------- ----------- -----------
TOTAL COSTS AND EXPENSES 1,482,989 430,041 331,570
----------- ----------- -----------
Income (loss) from continuing operations
before provision for (recovery of)
income taxes (1,170,018) (75,012) 1,432
Provision for (recovery of) income taxes (217,724) (23,398) 228
----------- ----------- -----------
Income (loss) from continuing operations
before partnership income (952,294) (51,614) 1,204
Income from a limited partnership -
net of income taxes 80 1,370 1,953
----------- ----------- -----------
NET INCOME (LOSS) $ (952,214) $ (50,244) $ 3,157
=========== =========== ===========
PRIMARY
Weighted average shares outstanding 3,327,500 3,123,406 2,350,000
=========== =========== ===========
Earnings (loss) per share amounts $ (.29) $ (.02) $ -Nil-
=========== =========== ===========
FULLY DILUTED
Weighted average shares outstanding 5,282,500 5,282,500 2,350,000
=========== =========== ===========
Earnings (loss) per share amounts $ (.18) $ (.01) $ -Nil-
=========== =========== ===========
</TABLE>
See Notes to Consolidated Financial Statements.
F-5
<PAGE>
R.F. MANAGEMENT CORP.
Consolidated Statements of Stockholders' Equity
Years Ended September 30, 1996, 1995 and 1994
<TABLE>
<CAPTION>
Additional Retained
Number of Common Paid-in Subscriptions Earnings
Shares Stock Capital Receivable (Deficit) Total
------ ----- ------- ---------- --------- -----
<S> <C> <C> <C> <C> <C> <C>
BALANCE, SEPTEMBER 30,
1993 2,000,000 $200 $ 800 $ -- $ 53,507 $ 54,507
Contributions from stockholders -- -- 4,880 (2,880) -- 2,000
Net income for the year ended
September 30, 1994 -- -- -- -- 3,157 3,157
--------- ---- ----------- ------- --------- -----------
BALANCE, SEPTEMBER 30,
1994 2,000,000 200 5,680 (2,880) 56,664 59,664
Net proceeds from issuance of
common stock - private
placement offering (net of
expenses of $84,005) 350,000 35 615,960 -- -- 615,995
Issuance of common stock -
collection of subscription
receivable -- -- -- 2,880 -- 2,880
Contribution of note payable -
shareholders -- -- 46,200 -- -- 46,200
Acquisition of Northern New Jersey
Medical Management, Inc. in a
manner similar to a pooling of
interests -- -- (750,000) -- -- (750,000)
Net proceeds from issuance of common
stock - initial public offering (net
of expenses of $1,365,851) 977,500 98 4,205,801 -- -- 4,205,899
Net loss for the year ended
September 30, 1995 -- -- -- -- (50,244) (50,244)
--------- ---- ----------- ------- --------- -----------
BALANCE, SEPTEMBER 30,
1995 3,327,500 333 4,123,641 -- 6,420 4,130,394
Net loss for the year ended
September 30, 1996 -- -- -- -- (952,214) (952,214)
--------- ---- ----------- ------- --------- -----------
BALANCE, SEPTEMBER 30,
1996 3,327,500 $333 $ 4,123,641 $ -- $(945,794) $ 3,178,180
========= ==== =========== ======= ========= ===========
</TABLE>
See Notes to Consolidated Financial Statements.
F-6
<PAGE>
R.F. MANAGEMENT CORP.
Consolidated Statements of Cash Flows
Years Ended September 30,
--------------------------------
1996 1995 1994
---------- --------- -------
Operating activities
Net income (loss) $ (952,214) $(50,244) $ 3,157
Adjustments to reconcile net income
(loss) to net cash provided by
(used in) operating activities
Depreciation and amortization 22,817 1,836 242
Deferred income taxes (218,347) (28,159) 1,851
Changes in operating assets and
liabilities
Accounts receivable (206,275) 33,473 10,469
Other current assets (84,785) (34,284) (512)
Accounts payable and accrued
expenses 336 79,184 751
Income taxes payable (3,825) 3,825 (379)
Other receivables -- -- --
---------- -------- -------
Net cash provided by (used
in) operating activities (1,442,293) 5,631 15,579
---------- -------- -------
Investing activities
Fixed asset additions (123,357) (28,500) (2,843)
Investment in a limited partnership (135) (2,317) (2,326)
Investment in joint venture (350,000) -- --
Investment in certificate of deposit (408,266) -- --
Acquisition of subsidiary -- (150,000) --
Note receivable 20,000 (20,000) --
Deposits and other assets (75,836) -- (4,230)
---------- -------- -------
Net cash used in
investing activities (937,594) (200,817) (9,399)
---------- -------- -------
See Notes to Consolidated Financial Statements.
F-7
<PAGE>
R.F. MANAGEMENT CORP.
Consolidated Statements of Cash Flows
(continued)
<TABLE>
<CAPTION>
Years Ended September 30,
------------------------------------
1996 1995 1994
----------- ----------- --------
<S> <C> <C> <C>
Financing activities
Organizational expenses $ -- $ (268) $ --
Deferred offering costs -- 1,116 (1,116)
Repayment to stockholders (150,000) (15,000) (18,170)
Sale of common stock -- 4,824,774 2,000
Advances from line of credit 167,700 -- --
----------- ----------- --------
Net cash provided by (used in)
financing activities 17,700 4,810,622 (17,286)
----------- ----------- --------
Net increase (decrease) in cash and
cash equivalents (2,362,187) 4,615,436 (11,106)
Cash and cash equivalents - beginning 4,620,520 5,084 16,190
----------- ----------- --------
Cash and cash equivalents - end $ 2,258,333 $ 4,620,520 $ 5,084
=========== =========== ========
Supplemental disclosures of cash flow information
Cash paid during the year for
Interest $ 49,418 $ 9,672 $ --
Income taxes $ 600 $ 3,825 $ 937
Noncash transactions
Issuance of notes payable to stockholders in
connection with the acquisition of subsidiary $ -- $ 600,000 $ --
Contribution of note payable -
shareholders to additional paid-in capital $ -- $ 46,200 $ --
</TABLE>
See Notes to Consolidated Financial Statements.
F-8
<PAGE>
R.F. MANAGEMENT CORP.
Notes to Consolidated Financial Statements
September 30, 1996 and 1995
Note 1. Organization and Business
R.F. Management Corp. ("R.F.") was incorporated in the State of New York on
August 4, 1994. R.F. issued 2,000,000 shares (after giving effect to the 4-for-1
stock split on December 22, 1994) (see note 3) of its $0.0001 par value common
stock at an average price of $0.0024 per share (after giving effect to the
4-for-1 stock split on December 22, 1994) for a total of $4,880. R.F.'s business
is to provide management advisory and other services in connection with the
establishment and operation of free standing, outpatient centers performing
ambulatory surgery and diagnostic imaging. R.F. offers a full range of services,
including contract negotiations, site selection, equipment procurement,
construction, office personnel and physician staffing, office management,
patient scheduling, patient billing, cash collections, personnel management and
marketing.
Note 2. Summary of Significant Accounting Policies
Principles of Consolidation
The consolidated financial statements include the accounts of R.F. Management
Corp. ("R.F.") and its wholly-owned subsidiaries, Northern New Jersey Medical
Management, Inc. ("Northern"), and R.F. Management Corp. of Toms River,
collectively the "Company". Northern was incorporated in the State of New Jersey
on January 25, 1986. R.F. acquired all of the outstanding capital stock (one
hundred [100] shares of no par value common stock) of Northern on May 31, 1995.
The Company accounted for the acquisition of Northern in a manner similar to a
pooling of interests due to the stockholders' common control of both R.F. and
Northern. On March 20, 1996, R.F. formed a wholly-owned subsidiary, R.F.
Management Corp. of Toms River "RFTR", a New Jersey corporation.
Cash and cash equivalents
The Company considers all highly liquid debt instruments purchased with a
maturity of three months or less to be cash equivalents.
Accounts receivable
Accounts receivable is stated net of contractual allowances. Based upon its past
history, the Company estimates the amount of the accounts receivable it does not
expect to receive. The Company values its uncollected accounts receivable as
part of its determination of profit and constantly reviews the valuation. The
continuing review and gathering of additional information, as well as changing
reimbursement rates, may cause adjustment. In addition, the Company, in the
normal course of business, extends revolving loans secured by accounts
receivable, to affiliated companies.
Furniture, Fixtures, Equipment and Leasehold Improvements
Furniture, fixtures, equipment and leasehold improvements are stated at cost.
Depreciation is provided for using the straight-line method over the estimated
useful lives of the related asset, five to ten years for office equipment,
furniture and fixtures, and leasehold improvements by charges to income.
Organizational expenses
Organizational expenses incurred in the set-up of the Company have been
capitalized and will be amortized over a period of five (5) years from the
commencement of operations.
Deferred offering costs
All deferred offering costs incurred by the Company in conjunction with the
private placement offering and initial public offering (IPO) have been charged
to additional paid-in capital upon the completion of the offering (see note 3).
continued...
F-9
<PAGE>
R.F. MANAGEMENT CORP.
Notes to Consolidated Financial Statements
September 30, 1996 and 1995
Note 2: Summary of Significant Accounting Policies (Continued)
Revenue recognition
Management fees are generated, through a contractual agreement between the
Company and a limited partnership, Union Diagnostic Facilities Group, L.P.
("Union"), based on a percentage of revenues generated. The Company recognizes
management fees when diagnostic imaging services are rendered by Union. The
Company owns a minority interest and is the general partner and managing agent.
The Company's responsibilities include the management of all personnel, leasing
of operating facilities and equipment, negotiation of contracts, payment of
debts and obligations and preparation and review of invoices and claims.
Use of Estimates
The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect certain reported amounts and disclosures. Accordingly, actual results
could differ from those estimates.
Reclassification
The September 30, 1995 financial statement have been reclassified to conform to
the 1996 presentation. Such reclassifications had not effect on net loss.
Income taxes
Effective October 1, 1993, the Company has adopted Financial Accounting
Standards Board (FASB) Statement of Financial Accounting Standards (SFAS) No.
109, "Accounting for Income Taxes", for financial statement reporting purposes,
which required a change from the deferred method (APB 11) to the assets and
liability method of accounting for income taxes. The assets and liability
approach requires the recognition of deferred tax assets and liabilities for the
expected future tax consequences of temporary differences between the carrying
amounts and the tax bases of assets and liabilities and the effect of future tax
planning strategies to reduce any deferred tax liability. Under this method,
deferred tax liabilities and assets are determined based on the differences
between the financial statement carrying amounts and tax basis of assets and
liabilities using enacted rates in effect in the years in which the differences
are expected to reverse. The adoption of SFAS 109 did not have a material impact
on the consolidated financial statements.
Income (Loss) per Common Share
Income (loss) per common share is computed by dividing the net income (loss) by
the weighted average number of common shares and common equivalent shares
outstanding during each period.
Year end
The Company has adopted a September 30 year end.
Fair Value of Financial Instruments
The carrying amounts of cash and cash equivalents, contracts receivable,
accounts payable and short-term debt approximate fair value due to the short
maturity of the instruments and the provision for what management believes to be
adequate reserves for potential losses. It was not practicable to estimate the
fair value of long-term debt because quoted market prices do not exist and an
estimate could not be made through other means without incurring excessive
costs.
F-10
<PAGE>
R.F. MANAGEMENT CORP.
Notes to Consolidated Financial Statements
September 30, 1996 and 1995
Note 3. Stockholders' Equity
Private Placement Offering
In August 1994, the Board of Directors of the Company passed a resolution
authorizing the management of the Company to initiate steps to make a private
placement of the Company's securities in order to raise capital. On December 22,
1994, the Company's common stock was split 4-for-1. The effect of the split is
being reflected retroactively. In December of 1994, the Company completed an
offering of its securities under an exemption pursuant to Regulation D - Rules
Governing the Limited Offer and Sale of Securities Without Registration Under
the Securities Act of 1933. The $800,000 offering was to include the sale of
400,000 shares (after giving effect to the 4-for-1 stock split) of the Company's
$0.0001 par value voting common stock at the offering price of $2.00 per share
(after giving effect to the 4-for-1 stock split). The offering closed on
December 15, 1994, with the sale of 350,000 shares (after giving effect to the
4-for-1 stock split on December 22, 1994) of the Company's $0.0001 par value
voting common stock at the offering price of $2.00 per share (after giving
effect to the 4-for-1 stock split), that raised an aggregate of $615,995, net of
expenses of $84,005, for the Company.
Initial Public Offering
In December 1994, the Board of Directors of the Company passed a resolution
authorizing the management of the Company to initiate steps to make an initial
public offering (IPO) of the Company's securities in order to raise capital.
Management was granted authority to file a registration statement (on Form S-1)
with the United States Securities and Exchange Commission (SEC) pursuant to the
Securities Act of 1933 (as amended) and to register the securities in any state
jurisdiction that management felt was required and appropriate. The initial
public offering called for the Company to offer up to 850,000 shares (977,500
shares if the underwriter's over-allotment is exercised) of common stock (the
"Common Stock") at $5.50 per share, 850,000 (977,500, if the underwriter's
over-allotment is exercised) Class A Redeemable Common Stock Purchase Warrants
(the "A warrants") at $0.10 per warrant and 850,000 (977,500 if the
underwriter's over-allotment is exercised) Class B Redeemable Common Stock
Purchase Warrants (the "B Warrants") at $0.10 per warrant. Each A Warrant
entitles the holder to purchase one (1) share of Common Stock for a period of
eighteen (18) months from the effective date of the offering at a price of
$5.50. Each B Warrant entitles the holder to purchase one (1) share of Common
Stock for a period of thirty-six (36) months from the effective date of the
offering at a price of $7.00. The offering was declared effective by the United
States Securities and Exchange Commission on July 21, 1995, and closed on July
27, 1995 with the sale of 977,500 shares of Common Stock, 977,500 A Warrants and
977,500 B Warrants, and raised an aggregate of $4,205,899, net of expenses of
$1,365,851, for the Company.
Note 4. Furniture, Fixtures, Equipment and Leasehold Improvements
Furniture, fixtures, equipment and leasehold improvements and related
accumulated depreciation as of September 30, 1996 and 1995 consist of the
following:
Estimated September 30,
Useful Lives - ---------------------
Years 1996 1995
-------------- -------- -------
Equipment 5 - 10 $118,990 $32,343
Furniture and fixtures 5 34,978 -
Leasehold improvements 5 1,731 -
-------- -------
Total 155,699 32,343
Less: accumulated depreciation
and amortization 24,969 2,201
-------- -------
Total furniture, fixtures, equipment
and leasehold improvements, net $130,730 $30,142
======== =======
F-11
<PAGE>
R.F. MANAGEMENT CORP.
Notes to Consolidated Financial Statements
September 30, 1996 and 1995
Note 5. Investment in a Limited Partnership
The Company has a one percent (1%) ownership in Union Diagnostic Facilities
Group, L.P. The investment is recorded on the equity method since the Company is
the only general partner. The Company's duties include contract negotiations,
site selection, equipment procurement, construction, office personnel and
physician staffing, office management and marketing. The Company records its
investment in the limited partnership and its income from the limited
partnership monthly. Currently, 100% of the Company's management fee revenue is
generated from this Limited Partnership.
Effective January 1, 1995, the limited partnership changed its reporting period
from December 31 to September 30, for financial statement purposes. The
following is a summary of condensed financial data from the audited financial
statements of the limited partnership in which the Company has an investment at
September 30, 1996 and 1995 and December 31, 1994, 1993 and 1992:
Total Long-Term Total Total
Assets Debt Liabilities Capital
-------- --------- ----------- --------
September 30, 1996 $821,822 $102,702 $402,117 $419,704
September 30, 1995 703,809 56,175 251,117 452,692
December 31, 1994 629,545 69,004 240,138 389,407
December 31, 1993 331,949 -- 99,287 232,662
Assets Liabilities
--------------------- ---------------------
Non- Non-
Current Current Current Current
------- ------- ------- -------
September 30, 1996 $454,465 $367,356 $299,415 $102,702
September 30, 1995 445,849 257,960 194,942 56,175
December 31, 1994 405,566 223,979 171,134 69,004
December 31, 1993 214,488 117,461 99,287 --
Net Net Allocation
Revenues Income of Income
-------- ------ ---------
September 30, 1996 $1,642,128 $ 13,637 $ 135
September 30, 1995 1,243,165 169,285 1,693
December 31, 1994 1,648,846 249,495 2,495
December 31, 1993 1,454,038 181,800 1,818
December 31, 1992 1,341,140 155,461 1,555
Gross profit and income from continuing operations does not differ from net
income. The partnership has no redeemable securities or minority interest.
Note 6. Note receivable
Note receivable consists of a $20,000 note which bears interest at 9% per annum
and is due on or before April 1, 2000. This note is secured by one Limited
Partnership share in Union Diagnostic Facilities Group, L.P. The note was repaid
in full in June 1996.
F-12
<PAGE>
R.F. MANAGEMENT CORP.
Notes to Consolidated Financial Statements
September 30, 1996 and 1995
Note 7. Income taxes
The Company does not report income, for income tax reporting purposes, on the
accrual basis. As a result of the adoption of SFAS 109, the Company has recorded
deferred income taxes payable at September 30, 1996 and 1995 of $43,257 and
$46,356, respectively, and has recorded deferred income tax assets at September
30, 1996 and 1995 of $262,055 and $46,807, respectively, which represent
temporary differences arising primarily from recognition of income on the cash
receipts and cash disbursements basis of accounting for income tax reporting
purposes at the statutory rates of 34% for federal income tax purposes and 8%
and 9% for state income tax purposes, which are expected to be realized in
future years.
The Company has recorded total income tax expenses (credits) for the years ended
September 30, 1996, 1995 and 1994 of ($217,669) ($22,451) and $601,
respectively. The Company has a net operating loss (NOL) carryforward for
federal income tax purposes of approximately $1,273,000 and $112,000 at
September 30, 1996 and 1995, respectively, available to offset income taxes in
future years through the year ended September 30, 2011.
Income (loss) before income taxes, income taxes (recovery), partnership income,
income tax expense on partnership income and net income (loss) are as follows:
September 30,
-------------------------------
1996 1995 1994
----------- -------- ------
Income (loss) before income taxes $(1,170,018) $(75,012) $1,432
Income taxes (recovery) (217,724) (23,398) 228
----------- -------- ------
(952,294) (51,614) 1,204
----------- -------- ------
Partnership income 135 2,317 2,326
Income tax expense on partnership income 55 947 373
----------- -------- ------
80 1,370 1,953
----------- -------- ------
Net income (loss) $ (952,214) $(50,244) $3,157
=========== ======== ======
The following is a reconciliation of the U.S. federal statutory tax rate and the
apparent tax rate:
September 30,
----------------------------
1996 1995 1994
----- ----- -----
U.S. Federal tax (34.00%) (34.00%) 34.00%
State taxes, net of federal tax benefit (6.00%) (6.00%) 6.00%
Benefit from net operating loss (NOL)
carryforward -- 12.13% (22.82%)
Valuation allowance 20.88% -- --
Other 0.51% (3.32%) (1.26%)
----- ----- -----
Apparent tax rate (18.61%) (31.19%) 15.92%
===== ===== =====
continued...
F-13
<PAGE>
R.F. MANAGEMENT CORP.
Notes to Consolidated Financial Statements
September 30, 1996 and 1995
Note 7: Income Taxes (Continued)
Temporary differences and carryforwards which give rise to a significant portion
of deferred tax assets and liabilities at September 30, 1996 are as follows:
Gross Deferred Tax
Amount Assets Liabilities
------ ------ -----------
Accounts receivable $ 84,649 $ -- $34,579
Accumulated depreciation 18,447 -- 7,535
Investment in a limited partnership 2,797 -- 1,143
Accounts payable and accrued expenses 472 193 --
Net operating loss carryforwards 1,272,655 506,132 --
-------- -------
Sub-total 506,325 43,257
Valuation allowances 488,540 244,270 --
-------- -------
Deferred tax assets and liabilities $262,055 $43,257
======== =======
Temporary differences and carryforwards which give rise to a significant portion
of deferred tax assets and liabilities at September 30, 1995 are as follows:
Gross Deferred Tax
Amount Assets Liabilities
------ ------ -----------
Accounts receivable $ 90,618 $ -- $37,018
Accumulated depreciation 18,290 -- 7,471
Investment in a limited partnership 4,571 -- 1,867
Accounts payable and accrued expenses 5,831 2,382 --
Net operating loss carryforwards 112,403 44,425 --
-------- ------- -------
Sub-total 46,807 46,356
Valuation allowances -- --
------- -------
Deferred tax assets and liabilities $46,807 $46,356
======= =======
The Company has recorded current and deferred income taxes, including income tax
expense on partnership income as follows:
Current Deferred Total
------- -------- -----
Year ended September 30, 1996 $ 1,081 $ 724 $1,805
Year ended September 30, 1995 349 598 947
Year ended September 30, 1994 (1,250) 1,851 601
F-14
<PAGE>
R.F. MANAGEMENT CORP.
Notes to Consolidated Financial Statements
September 30, 1996 and 1995
Note 8. Related Party Transactions
Operating expenses
The Company maintains an office at 95 Madison Avenue, Suite 301, Morristown, New
Jersey. Expenses incurred in the operation of the Company's office facility
including rent, telephone and office expenses are allocated to numerous
businesses which share the facility. The allocations are based on usage and
revenues. Management believes that the allocations are reasonable and proper.
The expenses for the years ended September 30, 1996, 1995 and 1994 aggregated
$63,560, $12,142 and $17,575, respectively. During the year ended September 30,
1996, the Company paid $60,000 for consulting services to an affiliated company.
Furthermore, during the year ended September 30, 1996, the Company acquired
software from another related party at an approximate cost of $35,000.
The Company entered into an agreement with an affiliated company to provide
marketing services to the Company. For the year ended September 30, 1996,
compensation for services totalled approximately $50,000.
The Company has entered into an agreement with two affiliated companies to
finance a portion of the affiliates' accounts receivable. At September 30, 1996,
there was a total balance outstanding of approximately $111,000.
Included in other assets, the Company has an outstanding note receivable from
one of its officers for approximately $24,000. The conditions and repayment
terms of the note have not yet been determined.
Note 9. Acquisitions
On May 31, 1995, R.F. Management Corp. (R.F.) acquired one hundred percent
(100%) of the outstanding shares (one hundred [100] shares of no par value
common stock) of Northern New Jersey Medical Management, Inc. ("Northern"), a
New Jersey Corporation, engaged in the management of a medical diagnostic
facility in Union, New Jersey. The terms of the agreement call for a payment of
one hundred and fifty thousand dollars ($150,000) and a six hundred thousand
dollar ($600,000) note, which bears interest at prime plus one percent (1%) and
requires principal payments of one hundred and fifty thousand dollars
($150,000), plus accrued interest, on January 30, 1996, 1997, 1998 and 1999. The
annual principal payments are subject to a one-third (1/3) reduction in the
event that the gross revenues of Northern fall below two hundred thousand
dollars ($200,000) per annum. The Company accounted for the business combination
in a manner similar to a pooling of interests due to the stockholders' common
control of both R.F. and Northern.
On December 27, 1995, R.F. acquired forty percent (40%) of the outstanding
shares of Mobile Medical Services Limited ("Mobile"), a privately held Company
incorporated in Ireland, and a fifty one percent (51%) interest in the property
owned or leased by its subsidiaries for $350,000. The payment terms call for the
Company to make payments directly to designated creditors on behalf of Mobile.
As of September 30, 1996, $350,000 is reflected as an investment in joint
venture.
Note 10. Line of Credit
On April 30, 1996, the Company entered into a one year $400,000 Line of Credit
agreement with a bank. Interest is payable on a quarterly basis at prime plus
one percent (9.25%). The line is collateralized by a certificate of deposit
which matures on April 30, 1997. As of September 30, 1996, the amount
outstanding under this line of credit aggregated approximately $168,000.
F-15
<PAGE>
R.F. MANAGEMENT CORP.
Notes to Consolidated Financial Statements
September 30, 1996 and 1995
Note 11. Commitments and Contingencies
Letter of intent and underwriters agreement
Pursuant to a signed letter of intent with Landmark Commodities, Inc. d/b/a
Landmark International Equities ("Landmark"), the Company has successfully
completed the sale of its securities in an initial public offering (IPO)(see
note 3). In addition, the Company has agreed to sell Landmark an option to
purchase 977,500 shares of Common Stock including the underwriter's
over-allotment, 977,500 A Warrants including the underwriter's over-allotment,
and 977,500 B Warrants including the underwriter's over-allotment for a period
of four (4) years at one-hundred and twenty percent (120%) of the offering price
($6.60, $0.12 and $0.12, respectively). In January 1995, the Company paid
Landmark $50,000, in advance, for financial consulting services. The services
are for the period from February 1, 1995 to January 31, 1996.
Employment agreement
Effective June 1, 1995, the Company entered into a two (2) year employment
agreement with its president. The agreement provides for an annual salary of
seventy thousand dollars ($70,000), plus benefits, and sets forth duties and
non-compete clauses.
Lease and Management Service Agreements
In April 1996, RFTR entered into an agreement to lease a 9,000 square foot
facility for five years with a base annual rental cost of $117,000. Included in
other assets at September 30, 1996 is approximately $19,500 of rental payments,
which will be expensed upon the opening of the facility
In July 1996, RFTR entered into a lease and management service agreement with
Surgical Associates, P.A. to provide space, equipment and nonprofessional
services, including management and billing and collection functions to a newly
formed Surgical Center.
On May 30, 1996, the Company entered into a five-year lease and management
Service Agreement with Associates in Otolaryngology of New Jersey, P.A. to
provide management, administrative marketing, operational and related services
to the physicians office in addition to providing the necessary fixtures and
equipment to be utilized in the practice. The Company has also guaranteed the
rental payments on the facility for the term of the management service
agreement. The five year term of this agreement commences with the completion of
the new facility construction.
Subsequent Events
On November 15, 1996, R.F. Management Corp. announced it is creating a mobile
MRI company, MobileTec, Inc., which will be a joint venture company with
MobileTec Management Corp. RF will own 75% of the joint venture company.
MobileTec Management Corporation will place its existing contracts and
operations into the joint venture, and will be responsible for the day to day
operations of the joint venture company.
F-16
<PAGE>
Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING AND FINANCIAL DISCLOSURE
Not Applicable.
PART III
Item 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT
The executive officers and directors of the Company are listed in the
table below and brief summaries of their business experience and certain other
information with respect of them are set forth thereafter:
Name Age Position
---- --- --------
Roger Findlay 48 Chairman of the Board of
Directors, President and
Principal Executive Officer
Wayne P. Miller 45 Vice President, Secretary
and Director
Louis A. D'Esposito 63 Vice President, Chief
Financial Officer and
Director
Each of the above officers and directors shall hold office until the next
annual meeting of the Company's shareholders and until a successor is selected
and qualified.
Roger Findlay is co-founder and has been President of the Company since
its inception. Since June 1990, Mr. Findlay is also co-founder, President and
Chairman of the Board of Modern Medical Modalities Corporation, a public company
listed on Nasdaq Small Capital Market, that leases magnetic resonance imaging
and computerized axial tomography equipment to hospitals and physicians ("Modern
Medical"). Mr. Findlay since 1989 has also been co-founder of Technology
Services, Inc. a software support company for medical offices and commercial
accounts ("Technology Services"). Mr. Findlay from 1986-1989 was President of
Advacare, Inc., a practice management and physician billing company. He was
co-founder and President of Effective Management Services, Inc., from 1984 to
1986, which provided facilities management and custom programming for hospitals,
universities and physician groups. Mr. Findlay from 1984 to 1986 was also
co-founder and President of Medical Accounts Management Services, a software
development company. Additionally, from 1986 he has been founder and President
of Northern New Jersey Medical Management, Inc., a general partner of a
diagnostic imaging center. From 1984 to 1986, Mr. Findlay was chief operating
officer of NMR of America, Inc., a publicly traded Company engaged in MRI sites.
Mr. Findlay from 1972 to 1986 was
21
<PAGE>
President and co-owner of Medical Billing Services. Mr. Findlay will devote his
full time to the affairs of the Company.
Wayne P. Miller has been Vice President, Secretary and Director of the
Company since December 1995. Mr. Miller from December 1989 to November 1995 was
employed by Modern Medical Modalities Corp., a company that leases magnetic
resonance imaging and computerized axial tomography equipment to hospitals and
physicians, and then by its wholly owned subsidiary Medical Marketing &
Management Inc. as National Marketing/Sales Director. Since 1991 Mr. Miller has
been employed by The Physicians Network, a company that provides turnkey medical
billing systems to billing companies, hospitals and physicians. From 1991 to
1995, Mr. Miller was an independent consultant providing billing and
computerized consulting services to physicians and hospitals. Mr. Miller from
1990 to 1991 was Vice President of Billing for Healthnet a company engaged in
the business of physician billing and receivable management. From 1986 to 1990,
Mr. Miller was Vice President of Marketing with HealthCare Technologies, a
company specializing in total turnkey physician billing solutions. Mr. Miller
from 1983 to 1986 was contracted by Health Corp. of the Archdiocese of Newark as
Vice President of PrimeMark, to establish a hospital based collection agency for
three hospitals and create a physician fee-for-service billing company for the
hospitals' billing procedures.
Louis A. D'Esposito has been Vice President, Chief Financial Officer and
Director of the Company since October 1995. From 1993 to 1995, Mr. D'Esposito
was the Eastern Regional Manager of DVI Financial Services, Inc., an equipment
leasing and finance company specializing in the leasing and financing of
high-tech medial equipment. Mr. D'Esposito from 1983 to 1993 was the Regional
Manager of U.S. Concord, Inc. a division of the Hong Kong and Shanghai Banking
Corporation, also specializing in the leasing and financing of medical
equipment.
22
<PAGE>
Executive Compensation
The following table sets forth the executive compensation and distribution
paid to each executive officer of the Company during the Year ended September
30, 1996.
EXECUTIVE COMPENSATION TABLE
<TABLE>
<CAPTION>
- --------------------------------------------------------------------------------------------------------------------
Annual Compensation Long-Term Compensation
- --------------------------------------------------------------------------------------------------------------------
Name and Restricted
Principal Fiscal Other Stock Options/ LTIP All Other
Other Position Year Salary Bonus Compensation Awards SARSs Payouts Compensation
- --------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C> <C>
Roger Findlay
President 1996 115,392 -- -- -- -- -- --
and Director
Wayne P. Miller
Vice President, 1996 46,153 -- -- -- -- -- --
Secretary
and Director
Louis A. D'Esposito
Vice President, 1996 67,345 -- -- -- -- -- --
Chief Financial
Officer and Director
- --------------------------------------------------------------------------------------------------------------------
</TABLE>
Employment Contracts.
In May 1995, the Company entered into an employment agreement with Roger
Findlay which provides for a two year term of employment, commencing in June
1995 at a salary of $70,000 for each year. The agreement provides that Mr.
Findlay will not compete with the Company for a period of twelve (12) months
following the termination of his employment with the Company.
23
<PAGE>
Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The following table sets forth certain information regarding the
beneficial ownership of the Company's Common Stock as of the date of this
Prospectus, and as adjusted to reflect the sale of the Securities offered
hereby, based on information obtained from the persons named below, with respect
to the beneficial ownership of shares of Common Stock, by (i) each person who is
known by the Company to own beneficially more than 5% of the Company's
outstanding Common Stock; (ii) each of the Company's directors; and (iii) all
directors and officers of the Company as a group.
Name Amount
and Address and Nature
of Beneficial of Beneficial Percentage of Outstanding
Owner Ownership(2) Shares Presently Owned
- ------------------------- ------------- -------------------------
Roger Findlay(1)
95 Madison Avenue
Morristown, NJ 998,000 61%
Oak Knoll Management Corp.
Oak Knoll Road
Mendham, NJ 07945 644,000 39%
Wayne P. Miller -- --
8 Fredon-Greendale Road
Newton, NJ 07860
Louis A. D'Esposito -- --
29 Glen Drive
Bardonia, NY 10954
Officers and 1,642,000 100%
Directors
as a group
(3 Persons)(3)
(1) 644,000 shares of Mr. Findlay's 998,000 shares are owned by Oak Knoll
Management Corp. Alice Findlay is the sole Stockholder, Officer and
Director of Oak Knoll Management Corp. Alice Findlay is the wife of Roger
Findlay, who is a Principal Stockholder, the President and Chairman of the
Board of Directors of the Company. Roger Findlay has no affiliation with
Oak Knoll Management Corp. and disclaims beneficial ownership of such
shares.
(2) Unless otherwise noted, the Company believes that all persons named in the
table have sole voting and investment power with respect to all shares of
Common Stock beneficially owned by them. A person is deemed to be the
beneficial owner of
24
<PAGE>
securities that can be acquired by such person within 60 days from the
date of this Prospectus upon the exercise of warrants or options.
(3) Includes the shares owned by Oak Knoll Management Corp. Roger Findlay has
no affiliation with Oak Knoll Management Corp. and disclaims beneficial
ownership of the 644,000 shares.
Mr. Findlay may be deemed a "Parent" and "Founder" of the Company as these terms
are defined under the Securities Act of 1933, as amended.
Item 13. CERTAIN RELATIONSHIP AND RELATED TRANSACTIONS
The Company was incorporated as R.F. Management Corp. in the State of New
York on August 4, 1994, for the purpose of providing free standing or outpatient
centers performing ambulatory surgery.
In August, 1994, the Company issued 560,000 shares of Common Stock (giving
effect to the 4-for-1 stock split on December 22, 1994) to Roger Findlay in
consideration of Mr. Findlay's payment of $.01 per share. Mr. Findlay
subsequently transferred 206,000 shares of Common Stock (giving effect to the
4-for-1 stock split on December 22, 1994) to unaffiliated parties. In August,
1994, the Company also issued an aggregate of 120,000 shares of Common Stock
(giving effect to the 4-for-1 stock split on December 22, 1994) to Jan Goldberg
and 120,000 shares to Gregory Maccia, in consideration of payment of $.02 per
share. Mr. Findlay, Mr. Goldberg and Mr. Maccia may be deemed "Promoters" as
that term is defined under the Securities Act of 1933, as amended. There are no
additional transactions between Messrs. Findlay, Goldberg and Maccia, except as
delivered below.
In December of 1994, the Company completed an offering of its securities
under an exemption pursuant to Regulation D of the Securities Act of 1933. The
offering closed on December 15, 1994, with the sale of 350,000 shares of the
Company's voting common stock (giving effect to the 4-for-1 stock split on
December 22, 1994) at the offering price of $2.00 per share (giving effect to
the 4-for-1 stock split on December 22, 1994), that raised an aggregate of
$615,995 for the Company.
In May 1995, the Company entered into a Stock Acquisition Agreement (the
"Agreement") with Northern New Jersey Medical Management, Inc. ("Northern") a
corporation formed in the State of New Jersey in January 1986 with offices
located at 95 Madison Avenue, Morristown, New Jersey 07960. Northern administers
and manages a free standing outpatient center performing diagnostic services.
The sole officers, directors and principal shareholders of Northern were Roger
Findlay and Gregory Maccia, who are
25
<PAGE>
officers, directors and principal shareholders of the Company.
Pursuant to the terms of the Agreement, the Company purchased all of the
issued and outstanding shares of common stock of Northern. In consideration, the
Company will pay Messrs. Findlay and Maccia an aggregate of $750,000 in
accordance with the following terms:
$150,000 paid upon execution of the agreement; the balance of
$600,000 will be paid in the form of a promissory note, with
interest at prime plus 1% on the unpaid principal balance, payable
as follows:
$150,000 on January 30, 1996;
$150,000 on January 30, 1997;
$150,000 on January 30, 1998;
$150,000 on January 30, 1999.
In the event that the gross annual revenue for any calendar year from
1995-1998 for Northern falls below $200,000 then the payment due on January 30
of the subsequent year will be reduced by 1/3, and the amount left unpaid by
reason of such adjustment shall be forfeited. The Company and Northern further
agreed, that all payments pursuant to the promissory note will only be
distributed from operating revenues and not from the Use of Proceeds of the
offering. The Company will not use or finance the purchase of Northern with
proceeds from the offering.
For the past three years, Northern has generated gross revenues of
approximately $355,000, $333,002 and $281,445 and net income (loss) of $23,460,
$3,157 and ($10,394) for the years ended September 30, 1995, 1994 and 1993,
respectively.
In addition, both the Company and Northern made standard representations
and warranties with respect to their respective operations and affairs. Northern
now operates as a wholly owned subsidiary of the Company. Northern further
represented and warranted that its present contract in Union, New Jersey will
remain in full force and effect for an additional eleven years.
As a result of the acquisition of Northern, Messrs. Findlay and Maccia
have received and will continue to receive financial benefits consisting of
aggregate cash payments totalling $750,000. The Company did not obtain a
fairness opinion in connection with the Northern purchase price. The Company
relied upon its review of historical financial information as well as projected
future operation in determining the $750,000 purchase. Accordingly, there is no
assurance that unrelated parties would not have paid less for Northern than the
Company paid. Neither Mr. Findlay nor Mr. Maccia voted with respect to the
Company's acquisition of Northern. Mr. Goldberg, who was not affiliated with
Northern, approved the Company's purchase of Northern shares. Mr. Goldberg is an
officer and a director of the Company as well as Modern Medical Modalities
26
<PAGE>
Corporation, a company whose other officers and directors are Messrs. Findlay
and Maccia.
PART IV
Item 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K
(a)(1) The financial statements for R.F. Management Corp. and
subsidiaries are included in Part II Item 8 - See Index to
Financial Statements on Page F.
(a)(2) The following financial statements for Union Diagnostic
Facilities Group, L.P. are submitted herewith:
Page
----
Union Diagnostic Facilities Group, L.P.
Independent Auditors' Report F-17
Financial Statements
Balance Sheets F-18, F-19
Statements of Income F-20
Statements of Partners' Capital F-21
Statements of Cash Flows F-22
Notes to Financial Statements F-23, F-27
(a)(3) The following schedules for the years ended September 30, 1996,
1995 and 1994
R.F. Management Corp.
Schedule IV - Indebtedness of and to Related
Parties - Not Current F-28
Union Diagnostic Facilities Group, L.P.
Independent Auditors' Report on Accompanying
Information F-29
Schedule IV - Indebtedness of an to Related
Parties - Not Current F-30
Schedule VIII - Valuation and Qualifying Account F-31
(a)(4) Exhibits. Not Applicable.
(b) Reports on Form 8-K. Not Applicable
(c) Exhibits. Not Applicable.
27
<PAGE>
Item 14(a)
28
<PAGE>
Independent Auditors' Report
To the Partners:
Union Diagnostic Facilities Group, L.P.
We have audited the accompanying balance sheets of Union Diagnostic Facilities
Group, L.P. (a New Jersey limited partnership) as of September 30, 1996 and 1995
and the related statements of income, partners' capital and cash flows for the
year ended September 30, 1996, the nine months ended September 30, 1995 and for
the year ended December 31, 1994. These financial statements are the
responsibility of the company's management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We have conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audits to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly in all
material respects the financial position of Union Diagnostic Facilities Group,
L.P. as of September 30, 1996 and 1995 and the results of its operations and its
cash flows for the year ended September 30, 1996, the nine months ended
September 30, 1995 and for the year ended December 31, 1994 in conformity with
generally accepted accounting principles.
/s/ Davenport & Associates, PA
DAVENPORT & ASSOCIATES, PA
Certified Public Accountants
Colonia, New Jersey
November 20, 1996
F-17
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Balance Sheets
September 30, 1996 and 1995
1996 1995
-------- --------
Current Assets:
Cash and cash equivalents $ 27,613 $ 40,908
Accounts receivable (net of contractual
allowances and allowances for doubtful
accounts of $233,569 and $224,835
(Notes 1 and 4)
Other current assets 409,366 396,175
17,486 8,766
-------- --------
Total current assets
454,465 445,849
-------- --------
Fixed Assets (Notes 1 and 2):
Medical equipment
Furniture and fixtures 282,046 164,276
Computer equipment 11,813 7,091
Leasehold improvements 36,896 34,179
145,275 123,139
-------- --------
Less: accumulated depreciation 476,030 328,685
116,463 78,089
-------- --------
Net fixed assets
359,567 250,596
-------- --------
Other Assets
7,789 7,364
-------- --------
Total Assets
$821,821 $703,809
======== ========
See accompanying notes to financial statements.
F-18
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Balance Sheets
September 30, 1996 and 1995
1996 1995
-------- --------
Current Liabilities:
Current maturities of long-term debt (Note 3) $ 54,180 $ 18,172
Accounts payable and accrued expenses (Note 8) 245,235 176,770
-------- --------
Total current liabilities 299,415 194,942
Other Liabilities:
Long-term debt, net of current maturities
(Note 3) 102,702 56,175
-------- --------
Total liabilities 402,117 251,117
Commitments and contingencies (Notes 3, 5, 7 and 8)
Partners' capital 419,704 452,692
-------- --------
Total Liabilities and Partners' Capital $821,821 $703,809
======== ========
See accompanying notes to financial statements.
F-19
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Statements of Income
For the year ended September 30, 1996, the nine months
ended September 30, 1995 and the year ended December 31, 1994
<TABLE>
<CAPTION>
For the year For the nine For the year
ended months ended ended
September 30, September 30, December 31,
1996 1995 1994
---------- ---------- ----------
<S> <C> <C> <C>
Net revenue (Notes 1 and 4) $1,642,128 $1,243,165 $1,659,740
---------- ---------- ----------
Operating expenses:
Management fees (Note 8) 309,067 277,118 350,362
Office compensation 625,220 326,738 450,028
Payroll taxes 55,706 34,814 46,036
Medical supplies 173,207 143,615 168,053
Equipment leasing 27,816 4,067 34,017
Insurance and employee benefits 61,660 28,741 32,861
Rent (Note 7) 63,383 46,997 63,594
Provision for bad debts 13,102 8,359 10,894
Advertising and marketing costs 53,805 36,341 51,359
Office expense and printing 48,567 36,558 42,992
Computer costs 1,200 1,200 2,933
Postage and courier 36,402 27,897 23,169
Professional fees 17,456 12,456 19,271
Telephone 14,828 9,598 14,202
Utilities 11,999 8,824 11,393
Maintenance and repairs 62,792 36,134 59,304
Interest expense 10,706 7,905 6,619
Miscellaneous expenses and taxes 3,201 6,194 3,422
Depreciation expense 38,374 20,324 19,736
---------- ---------- ----------
Total operating expenses 1,628,491 1,073,880 1,410,245
---------- ---------- ----------
Net income $ 13,637 $ 169,285 $ 249,495
========== ========== ==========
</TABLE>
See accompanying notes to financial statements.
F-20
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Statements of Partners' Capital
For the year ended September 30, 1996, the nine months
ended September 30, 1995 and the year ended December 31, 1994
<TABLE>
<CAPTION>
For the year ended For the nine months ended For the year ended
September 30, September 30, December 31,
1996 1995 1994
-------- -------- --------
<S> <C> <C> <C>
Partners' capital - beginning of period $452,692 $389,407 $232,662
Net income during the period 13,637 169,285 249,495
-------- -------- --------
466,329 558,692 482,157
Less: distributions 46,625 106,000 92,750
-------- -------- --------
Partners' capital - end of period $419,704 $452,692 $389,407
======== ======== ========
</TABLE>
See accompanying notes to financial statements.
F-21
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Statements of Cash Flows
For the year ended September 30, 1996, the nine months
ended September 30, 1995, and the year ended December 31, 1994
<TABLE>
<CAPTION>
For the nine
For the year ended months ended For the year ended
September 30, September 30, December 31,
1996 1995 1994
------------------ ------------ ------------------
<S> <C> <C> <C>
Cash flows from (Note 6):
Operating activities:
Net income $ 13,637 $ 169,285 $ 249,495
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation 38,374 20,324 19,736
Contractual allowances 8,734 102,209 66,380
Changes in operating assets and
liabilities:
(Increase) decrease in accounts
receivable (21,925) (116,780) (268,181)
(Increase) decrease in other current
assets (5,339) (8,766) --
Increase (decrease) in accounts
payable 68,465 21,047 56,436
--------- --------- ---------
Net cash provided by operating activities 101,946 187,319 123,866
--------- --------- ---------
Investing activities:
Additions to fixed assets (147,345) (54,305) (32,808)
Increase in other assets (425) -- (815)
--------- --------- ---------
Net cash used in investing activities (147,770) (54,305) (33,623)
--------- --------- ---------
Financing activities:
Additions to long-term debt 105,210 -- --
Principal repayments of long-term debt (26,056) (10,068) (8,216)
Distributions during the period (46,625) (106,000) (92,750)
--------- --------- ---------
Net cash provided by (used in) financing
activities 32,529 (116,068) (100,966)
--------- --------- ---------
Net increase (decrease) in cash and cash
equivalents (13,295) 16,946 (10,723)
Cash and cash equivalents - beginning of
period 40,908 23,962 34,685
--------- --------- ---------
Cash and cash equivalents - end of period $ 27,613 $ 40,908 $ 23,962
========= ========= =========
</TABLE>
See accompanying notes to financial statements.
F-22
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Notes to Financial Statements
For the year ended September 30, 1996, the nine months
ended September 30, 1995 and the year ended December 31, 1994
1. Summary of Significant Accounting Policies:
The following is a summary of significant accounting policies employed in the
preparation of these financial statements. The policies conform to generally
accepted accounting principles and have been consistently applied.
a. Line of Business
Union Diagnostic Facilities Group, L.P. (a New Jersey limited
partnership) was formed on October 15, 1986. The Company operates
and manages the office of a medical practice.
b. Cash and Cash Equivalents
For purposes of the statement of cash flows, the Company considers
all highly liquid investments with a maturity of three months or
less at the time of purchase to be cash equivalents.
c. Accounts Receivable
Accounts receivable is stated net of contractual allowances and
reserves for uncollectible accounts. Based upon its past history,
the Company estimates the amount of the accounts receivable it does
not expect to receive. The Company values its uncollected accounts
receivable as part of its determination of profit and constantly
reviews the valuation. The continuing review and gathering of
additional information, as well as changing reimbursement rates, may
cause adjustments.
b. Fixed Assets
Fixed assets are stated at cost. Depreciation is provided for by
charges to income over the estimated useful lives of the assets by
the straight-line method for financial reporting purposes and by
accelerated methods for tax reporting purposes. At the time of
retirement or other disposition of fixed assets, the cost and
accumulated depreciation are removed from the accounts and any gains
or losses are reflected in the statement of income. Maintenance,
repairs and minor renewals are charged to income as incurred except
that expenditures which substantially increase the useful lives of
the respective properties are capitalized.
e. Revenue Recognition:
The Company recognizes revenue from services upon performance. The
Company reports its revenues and expenses on the accrual basis of
accounting for financial statement reporting purposes and on the
cash basis for income tax reporting purposes.
F-23
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Notes to Financial Statements
For the year ended September 30, 1996, the nine months
ended September 30, 1995 and the year ended December 31, 1994
1. Summary of Significant Accounting Policies (continued):
f. Income Taxes:
The Company is organized as a limited partnership. Under this form
of organization, the earnings or losses are passed on directly to
the partners; therefore, there is no provision for federal or state
income taxes.
2. Depreciation:
The principal rates used in calculating depreciation are as follows:
Class Rates per Annum
--------------------------- -----------------------
Medical equipment 10%
Furniture and fixtures 10%
Computer equipment 14.3%
Leasehold improvements 2.5% - 10%
3. Long-Term Debt:
Long-term debt at September 30, 1996 and 1995 and December 31, 1994 consisted of
the following:
<TABLE>
<CAPTION>
September 30, September 30, December 31,
1996 1995 1994
------------ ------------ -----------
<S> <C> <C> <C>
Note payable in monthly installments of
principal and interest of $386, with
interest at 6.81% on the acquisition of
insurance, due in June 1997, unsecured,
net of interest $ 3,005 $ -- $ --
Note payable in monthly installments of
principal and interest of $2,061 with
interest at 12% per annum, due in May 1999,
secured by medical equipment, net of
interest 56,175 74,347 84,415
Note payable in monthly installments
of principal and interest of $3,444
with interest at 11% per annum, due
in June 1999, secured by medical
equipment, net of interest 97,702 -- --
-------- ------- -------
Net indebtedness 156,882 74,347 84,415
Less: amounts due within one year 54,180 18,172 15,411
-------- ------- -------
Long-term debt, net of current maturities $102,702 $56,175 $69,004
======== ======= =======
</TABLE>
F-24
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Notes to Financial Statements
For the year ended September 30, 1996, the nine months
ended September 30, 1995 and the year ended December 31, 1994
3. Long-Term Debt (continued):
The future principal payments for long-term debt as of September 30, 1996 and
1995 and December 31, 1994 are as follows:
September 30, September 30, December 31,
1996 1995 1994
------------ ------------ -----------
1995 $ -- $ -- $15,411
1996 -- 18,172 17,367
1997 54,179 18,998 19,575
1998 57,312 21,412 22,062
1999 45,391 15,765 10,000
-------- ------- -------
Total future minimum principal
payments $156,882 $74,347 $84,415
======== ======= =======
4. Operating Revenues:
Revenues from services to physicians are recorded at a percentage of the
physicians' established rates under contractual agreements between the Company
and the physicians. Under these agreements, the Company participates, on the
same percentage basis, with adjustments, known as contractual allowances, under
third party reimbursement agreements with the physicians deducted to arrive at
net revenue from services. A schedule of revenue and contractual allowances for
the year ended September 30, 1996, the nine months ended September 30, 1995 and
for the year ended December 31, 1994 is as follows:
September 30, September 30, December 31,
1996 1995 1994
------------ ------------ -----------
Revenues from services $2,620,190 $1,671,733 $2,178,708
Less: Contractual allowances 978,062 428,568 518,968
---------- ---------- ----------
Net revenue from services $1,642,128 $1,243,165 $1,659,740
========== ========== ==========
5. Reimbursement Contingencies:
The physicians with which the Company contracts, operate under various payment
systems with third party payors. A substantial portion of the Company's revenue
is attributable to payments made by government-sponsored health care programs
and other third party payors. Any change in reimbursement regulations, or the
enactment of legislation, which would have the effect of placing material
limitations on the amount of reimbursement for imaging services, could adversely
affect the operations of the Company. In addition, health care reimbursement
programs are not uniformly prompt in making required payments. Extensive payment
delays are not uncommon, and the Company's financial resources could be strained
while awaiting payment.
F-25
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Notes to Financial Statements
For the year ended September 30, 1996, the nine months
ended September 30, 1995 and the year ended December 31, 1994
6. Statements of Cash Flows:
The Company has adopted Financial Accounting Standards Board (FASB) Statement of
Financial Accounting Standard (SFAS) No. 95, "Statement of Cash Flows", for
financial reporting purposes. The statements of cash flows are presented for the
year ended September 30, 1996, the nine month period ended September 30, 1995
and for the year ended December 31, 1994. These statements present cash flow
information as well as the required supplemental information and the effects of
non-cash transactions during the periods and years presented.
The Company had non-cash investing and financing activity transactions during
the year ended September 30, 1996, the nine month period ended September 30,
1995 and for the year ended December 31, 1994.
Supplemental disclosures of cash flow information for the year ended September
30, 1996, the nine month period ended September 30, 1995 and for the year ended
December 31, 1994 are as follows:
September 30, September 30, December 31,
1996 1995 1994
------------ ------------ -----------
Cash paid during the year for:
Interest $10,706 $7,160 $ 6,619
Income taxes -- -- --
Non-cash transaction:
Equipment additions by notes
payable -- -- 92,631
Insurance additions by notes
payable 3,381 -- --
7. Lease:
The Company leased a facility under a five-year non-cancelable operating lease
which expired in March 1995. The facility is located in Union, New Jersey and
required monthly rental payments of $4,006 plus specified operating costs. The
lease was renewed for an additional five-year period expiring March 2000 and
requires a monthly rental of $4,945 plus specified operating costs. Future
minimum annual lease payments as of September 30, 1996 for each of the next five
years are as follows:
1997 $ 59,340
1998 59,340
1999 59,340
2000 29,670
--------
Total future minimum rental payments $207,690
========
F-26
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Notes to Financial Statements
For the year ended September 30, 1996, the nine months
ended September 30, 1995 and the year ended December 31, 1994
8. Related Party Transactions:
Management Agreement - the Company entered into a Management agreement with its
only general partner, Northern New Jersey Medical Management, Inc. ("Northern")
to manage the limited partnership. Northern's duties include contract
negotiations, site selection, equipment procurement, construction, office
personnel and physician staffing, office management, patient scheduling, patient
billing, cash collections, personnel management and marketing. Management fees
payable of $185,698, $100,118 and $100,877 are included in accounts payable and
accrued expenses at September 30, 1996 and 1995 and December 31, 1994,
respectively.
9. Reporting Period:
Effective January 1, 1995, the Company elected to change its reporting period
from December 31 to September 30 for financial statement purposes.
F-27
<PAGE>
Schedule IV
R.F. MANAGEMENT CORP.
Supplemental Schedule to Consolidated Financial Statements
For the years ended September 30, 1996, 1995 and 1994
Indebtedness of and to Related Parties - Not Current
Balance at Indebtedness of Balance
Name of person Beginning Additions Deductions at End
- -------------- ---------- --------- ---------- -------
Stockholders
For the year ended
September 30, 1996 $450,000 $ -- $150,000 $300,000
For the year ended
September 30, 1995 61,200 450,000 61,200 450,000
For the year ended
September 30, 1994 79,370 -- 18,170 61,200
F-28
<PAGE>
Independent Auditors' Report on Accompanying Information
Our audits of the basic financial statements as of September 30, 1996 and 1995
and December 31, 1994 and for the periods then ended, were made for the purpose
of forming an opinion on these financial statements taken as a whole. The
information included in Schedules IV and VIII (as required by Regulation S-X) is
presented for the purpose of additional analysis, and is not a required part of
the basic financial statements. Such information has been subjected to the
auditing procedures applied in the audits of the basic financial statements, and
in our opinion, is fairly presented in all material respects in relation to the
basic financial statements taken as a whole.
/s/ Davenport & Associates, PA
DAVENPORT & ASSOCIATES, PA
Certified Public Accountants
Colonia, New Jersey
November 20, 1996
F-29
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Supplemental Schedule to Financial Statements
For the year ended September 30, 1996, the nine months
ended September 30, 1995 and the year ended December 31, 1994
Schedule IV
Indebtedness of and to Related Parties - Not Current
<TABLE>
<CAPTION>
Indebtedness to
Balance at ----------------------- Balance
Name of person Beginning Additions Deductions at End
- -------------- --------- --------- ---------- --------
<S> <C> <C> <C> <C>
Northern New Jersey Medical Management, Inc.
For the year ended September 30, 1996 $100,118 $ 100,392 $ 14,812 $185,698
======== ========= ========= ========
For the nine months ended September 30, 1995 $100,877 $ -- $ 759 $100,118
======== ========= ========= ========
For the year ended December 31, 1994 $ 83,369 $ 17,508 $ -- $100,877
======== ========= ========= ========
</TABLE>
F-30
<PAGE>
UNION DIAGNOSTIC FACILITIES GROUP, L.P.
Supplemental Schedule to Financial Statements
For the year ended September 30, 1996, the nine months
ended September 30, 1995 and the year ended December 31, 1994
Schedule VIII
Valuation and Qualifying Accounts
<TABLE>
<CAPTION>
Balance at Charged to Charged Balance at
Beginning of Costs and to Other End of
Description Period Expenses Accounts Deductions Period
- ------------------------------------- ------------ ---------- -------- ---------- ----------
<S> <C> <C> <C> <C> <C>
Contractual allowances and
allowances for doubtful accounts
For the year ended September 30, 1996 $224,835 $ 8,734 $-- $-- $233,569
======== ======== ==== ==== ========
For the nine months ended
September 30, 1995 $122,626 $102,209 $-- $-- $224,835
======== ======== ==== ==== ========
For the year ended December 31, 1994 $ 56,246 $ 66,380 $-- $-- $122,626
======== ======== ==== ==== ========
</TABLE>
F-31
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities and
Exchange Act of 1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
R.F. MANAGEMENT CORP.
By /s/Roger Findlay
---------------------------------------------
Roger Findlay
Chairman of the Board of Directors,
President and Principal Executive Officer
Date January 29, 1997
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the dates indicated.
By /s/Roger Findlay
---------------------------------------------
Roger Findlay
Chairman of the Board of Directors,
President and Principal Executive Officer
Date January 29, 1997
* * *
By /s/Wayne P. Miller
---------------------------------------------
Wayne P. Miller
Director, Vice President and Secretary
Date January 29, 1997
* * *
By /s/Louis A. D'Esposito
---------------------------------------------
Louis A. D'Esposito
Director, Vice President and
Chief Financial Officer
Date January 29, 1997
<PAGE>
R.F. MANAGEMENT CORP.
COMPUTATION OF PER SHARE EARNINGS
Exhibit 11.1
Years Ended September 30,
--------------------------------------
1996 1995 1994
----------- ----------- ----------
NET INCOME (LOSS) $ (952,214) $ (50,244) $ 3,157
=========== =========== ==========
PRIMARY
Weighted average shares 3,327,500 2,607,802 2,350,000
Assumed conversions
A warrants and B warrants -- 515,604 --
----------- ----------- ----------
Total weighted average
shares outstanding 3,327,500 3,123,406 2,350,000
=========== =========== ==========
Earnings (loss) per share amounts $ (0.29) $ (0.02) $ -Nil-
=========== =========== ==========
FULLY DILUTED
Weighted average shares 3,327,500 3,327,500 2,350,000
Assumed conversions
A warrants and B warrants 1,955,000 1,955,000 --
----------- ----------- ----------
Total weighted average
shares outstanding 5,282,500 5,282,500 2,350,000
=========== =========== ==========
Earnings (loss) per share amounts $ (0.18) $ (0.01) $ -Nil-
=========== =========== ==========
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance, sheets and consolidated statements of operations of the
Company in its Annual filing on Form 10K and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
<S> <C> <C>
<PERIOD-TYPE> 12-MOS 12-MOS
<FISCAL-YEAR-END> SEP-30-1996 SEP-30-1995
<PERIOD-END> SEP-30-1996 SEP-30-1995
<CASH> 2,666,599 4,620,520
<SECURITIES> 0 0
<RECEIVABLES> 296,893 90,618
<ALLOWANCES> 0 0
<INVENTORY> 0 0
<CURRENT-ASSETS> 3,303,243 4,747,756
<PP&E> 155,699 32,343
<DEPRECIATION> 24,969 2,201
<TOTAL-ASSETS> 3,876,151 4,814,154
<CURRENT-LIABILITIES> 397,971 233,760
<BONDS> 300,000 450,000
0 0
0 0
<COMMON> 333 333
<OTHER-SE> 3,177,847 4,130,061
<TOTAL-LIABILITY-AND-EQUITY> 3,876,151 4,814,154
<SALES> 0 0
<TOTAL-REVENUES> 312,971 355,029
<CGS> 0 0
<TOTAL-COSTS> 1,482,989 430,041
<OTHER-EXPENSES> 0 0
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 0 0
<INCOME-PRETAX> (1,170,018) (75,012)
<INCOME-TAX> (217,724) (23,398)
<INCOME-CONTINUING> (952,294) (51,614)
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> (952,214) (50,244)
<EPS-PRIMARY> (.29) (.02)
<EPS-DILUTED> (.18) (.01)
</TABLE>
